• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄相关的黄斑变性的临床危险因素:系统评价和荟萃分析。

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.

机构信息

Centre for Vision Science, Queen's University Belfast, Northern Ireland, UK.

出版信息

BMC Ophthalmol. 2010 Dec 13;10:31. doi: 10.1186/1471-2415-10-31.

DOI:10.1186/1471-2415-10-31
PMID:21144031
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3009619/
Abstract

BACKGROUND

Age-related macular degeneration (AMD) is the leading cause of blindness in Western countries. Numerous risk factors have been reported but the evidence and strength of association is variable. We aimed to identify those risk factors with strong levels of evidence which could be easily assessed by physicians or ophthalmologists to implement preventive interventions or address current behaviours.

METHODS

A systematic review identified 18 prospective and cross-sectional studies and 6 case control studies involving 113,780 persons with 17,236 cases of late AMD that included an estimate of the association between late AMD and at least one of 16 pre-selected risk factors. Fixed-effects meta-analyses were conducted for each factor to combine odds ratio (OR) and/or relative risk (RR) outcomes across studies by study design. Overall raw point estimates of each risk factor and associated 95% confidence intervals (CI) were calculated.

RESULTS

Increasing age, current cigarette smoking, previous cataract surgery, and a family history of AMD showed strong and consistent associations with late AMD. Risk factors with moderate and consistent associations were higher body mass index, history of cardiovascular disease, hypertension, and higher plasma fibrinogen. Risk factors with weaker and inconsistent associations were gender, ethnicity, diabetes, iris colour, history of cerebrovascular disease, and serum total and HDL cholesterol and triglyceride levels.

CONCLUSIONS

Smoking, previous cataract surgery and a family history of AMD are consistent risk factors for AMD. Cardiovascular risk factors are also associated with AMD. Knowledge of these risk factors that may be easily assessed by physicians and general ophthalmologists may assist in identification and appropriate referral of persons at risk of AMD.

摘要

背景

年龄相关性黄斑变性(AMD)是西方国家致盲的主要原因。已有大量报道称存在多种风险因素,但关联的证据和强度各不相同。我们旨在确定那些具有较强证据水平的风险因素,这些因素可以由医生或眼科医生轻松评估,以实施预防干预或解决当前的行为。

方法

系统评价确定了 18 项前瞻性和横断面研究以及 6 项病例对照研究,共涉及 113780 名患者和 17236 例晚期 AMD,其中包括晚期 AMD 与至少 16 个预先选择的风险因素之间的关联估计。按研究设计对每个因素进行固定效应荟萃分析,以跨研究合并优势比(OR)和/或相对风险(RR)结果。计算每个风险因素的总体原始点估计值及其相关的 95%置信区间(CI)。

结果

年龄增长、当前吸烟、既往白内障手术和 AMD 家族史与晚期 AMD 有很强的一致性关联。具有中度和一致性关联的风险因素是较高的体重指数、心血管疾病史、高血压和较高的血浆纤维蛋白原。与性别、种族、糖尿病、虹膜颜色、脑血管疾病史以及血清总胆固醇和高密度脂蛋白胆固醇和甘油三酯水平相关的风险因素则较弱且不一致。

结论

吸烟、既往白内障手术和 AMD 家族史是 AMD 的一致危险因素。心血管危险因素也与 AMD 相关。了解这些风险因素,这些因素可能由医生和普通眼科医生轻松评估,可能有助于识别和适当转介有 AMD 风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/fe36a8c5804a/1471-2415-10-31-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/d1a2e1c799f3/1471-2415-10-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/4cff9b1cfcec/1471-2415-10-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/90166ffea283/1471-2415-10-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/918b64bfd2bd/1471-2415-10-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/3466eed73bb5/1471-2415-10-31-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/9801b188a38d/1471-2415-10-31-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/284f40abfe84/1471-2415-10-31-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/20f9c9adb812/1471-2415-10-31-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/9686df7c399a/1471-2415-10-31-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/718d80ceb273/1471-2415-10-31-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/db1a7f34b55d/1471-2415-10-31-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/8ea0ee4474a8/1471-2415-10-31-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/b5d984f5a6b2/1471-2415-10-31-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/fe36a8c5804a/1471-2415-10-31-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/d1a2e1c799f3/1471-2415-10-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/4cff9b1cfcec/1471-2415-10-31-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/90166ffea283/1471-2415-10-31-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/918b64bfd2bd/1471-2415-10-31-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/3466eed73bb5/1471-2415-10-31-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/9801b188a38d/1471-2415-10-31-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/284f40abfe84/1471-2415-10-31-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/20f9c9adb812/1471-2415-10-31-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/9686df7c399a/1471-2415-10-31-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/718d80ceb273/1471-2415-10-31-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/db1a7f34b55d/1471-2415-10-31-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/8ea0ee4474a8/1471-2415-10-31-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/b5d984f5a6b2/1471-2415-10-31-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca34/3009619/fe36a8c5804a/1471-2415-10-31-14.jpg

相似文献

1
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.与年龄相关的黄斑变性的临床危险因素:系统评价和荟萃分析。
BMC Ophthalmol. 2010 Dec 13;10:31. doi: 10.1186/1471-2415-10-31.
2
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
3
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
4
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
5
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
6
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2012 Jun 13;6(6):CD006757. doi: 10.1002/14651858.CD006757.pub3.
9
Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.非甾体抗炎药与皮质类固醇用于控制单纯性白内障手术后的炎症
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD010516. doi: 10.1002/14651858.CD010516.pub2.
10
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂可减缓与年龄相关的黄斑变性的进展。
Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5.

引用本文的文献

1
Development of a BALB/c mice model for blue light retinal damage.蓝光视网膜损伤BALB/c小鼠模型的建立。
J Adv Pharm Technol Res. 2025 Jul-Sep;16(3):139-143. doi: 10.4103/JAPTR.JAPTR_32_25. Epub 2025 Aug 9.
2
Integration of multi-omics data reveals dysregulated RNA methylation in retinal pigment epithelium drives age-related macular degeneration.多组学数据整合揭示视网膜色素上皮细胞中RNA甲基化失调驱动年龄相关性黄斑变性。
Int J Ophthalmol. 2025 Sep 18;18(9):1626-1639. doi: 10.18240/ijo.2025.09.03. eCollection 2025.
3
Causal associations between smoking and ocular diseases: a Mendelian randomization study.

本文引用的文献

1
Complement component C3 and risk of age-related macular degeneration.补体成分C3与年龄相关性黄斑变性的风险
Ophthalmology. 2009 Mar;116(3):474-480.e2. doi: 10.1016/j.ophtha.2008.09.055. Epub 2009 Jan 24.
2
Population-based studies in ophthalmology.眼科领域基于人群的研究。
Am J Ophthalmol. 2008 Nov;146(5):656-63. doi: 10.1016/j.ajo.2008.07.048.
3
Sunlight exposure, antioxidants, and age-related macular degeneration.阳光照射、抗氧化剂与年龄相关性黄斑变性
吸烟与眼部疾病之间的因果关联:一项孟德尔随机化研究。
Adv Ophthalmol Pract Res. 2025 Jun 14;5(3):220-225. doi: 10.1016/j.aopr.2025.06.002. eCollection 2025 Aug-Sep.
4
[Smoking and eye diseases].[吸烟与眼部疾病]
Ophthalmologie. 2025 Sep;122(9):753-762. doi: 10.1007/s00347-025-02299-3. Epub 2025 Jul 31.
5
Identification and validation of integrated stress-response-related genes as biomarkers for age-related macular degeneration.鉴定和验证整合应激反应相关基因作为年龄相关性黄斑变性的生物标志物
Front Mol Biosci. 2025 Jul 16;12:1583237. doi: 10.3389/fmolb.2025.1583237. eCollection 2025.
6
MiR-21-5p promotes RPE cell necroptosis by targeting Peli1 in a rat model of AMD.在年龄相关性黄斑变性大鼠模型中,微小RNA-21-5p通过靶向含PEST结构域的蛋白磷酸酶1促进视网膜色素上皮细胞坏死性凋亡。
In Vitro Cell Dev Biol Anim. 2025 Jun 30. doi: 10.1007/s11626-025-01064-9.
7
Determinants of Healthcare Professionals' Knowledge on Age-Related Macular Degeneration Risk Factors in Ethiopia.埃塞俄比亚医疗保健专业人员对年龄相关性黄斑变性风险因素的认知决定因素
Clin Ophthalmol. 2025 Jun 4;19:1771-1785. doi: 10.2147/OPTH.S514480. eCollection 2025.
8
Machine learning model for age related macular degeneration based on pesticides: the National Health and Nutrition Examination Survey 2007-2008.基于农药的年龄相关性黄斑变性机器学习模型:2007 - 2008年美国国家健康与营养检查调查
Front Public Health. 2025 Apr 16;13:1561913. doi: 10.3389/fpubh.2025.1561913. eCollection 2025.
9
Artemisinin and Its Derivatives: Promising Therapeutic Agents for Age-Related Macular Degeneration.青蒿素及其衍生物:治疗年龄相关性黄斑变性的有前景的治疗药物。
Pharmaceuticals (Basel). 2025 Apr 6;18(4):535. doi: 10.3390/ph18040535.
10
Sex-Specific Multimorbidity-Multibehaviour Patterns in Primary Care Populations.基层医疗人群中特定性别的多种疾病-多种行为模式
Int J Environ Res Public Health. 2025 Mar 24;22(4):485. doi: 10.3390/ijerph22040485.
Arch Ophthalmol. 2008 Oct;126(10):1396-403. doi: 10.1001/archopht.126.10.1396.
4
Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study.亚洲人中的吸烟、心血管危险因素与年龄相关性黄斑变性:新加坡马来人眼研究
Am J Ophthalmol. 2008 Dec;146(6):960-7.e1. doi: 10.1016/j.ajo.2008.06.026. Epub 2008 Aug 23.
5
Age-related macular degeneration.年龄相关性黄斑变性
N Engl J Med. 2008 Jun 12;358(24):2606-17. doi: 10.1056/NEJMra0801537.
6
Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis.膳食ω-3脂肪酸和鱼类摄入在年龄相关性黄斑变性一级预防中的作用:一项系统评价和荟萃分析。
Arch Ophthalmol. 2008 Jun;126(6):826-33. doi: 10.1001/archopht.126.6.826.
7
Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis.炎症、补体因子H与年龄相关性黄斑变性:动脉粥样硬化多民族研究
Ophthalmology. 2008 Oct;115(10):1742-9. doi: 10.1016/j.ophtha.2008.03.021. Epub 2008 Jun 5.
8
Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study.马来人群中年龄相关性黄斑变性的患病率:新加坡马来眼研究
Ophthalmology. 2008 Oct;115(10):1735-41. doi: 10.1016/j.ophtha.2008.02.012. Epub 2008 Apr 25.
9
Phacoemulsification does not induce neovascular age-related macular degeneration.超声乳化术不会诱发新生血管性年龄相关性黄斑变性。
Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1079-83. doi: 10.1167/iovs.07-0557.
10
Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis.饮酒与年龄相关性黄斑变性风险:一项系统评价与荟萃分析。
Am J Ophthalmol. 2008 Apr;145(4):707-715. doi: 10.1016/j.ajo.2007.12.005. Epub 2008 Feb 1.